[HTML][HTML] Nanoparticles for targeted brain drug delivery: what do we know?

RGR Pinheiro, AJ Coutinho, M Pinheiro… - International Journal of …, 2021 - mdpi.com
The blood–brain barrier (BBB) is a barrier that separates the blood from the brain tissue and
possesses unique characteristics that make the delivery of drugs to the brain a great …

Drug targeting to the brain

AG De Boer, PJ Gaillard - Annu. Rev. Pharmacol. Toxicol., 2007 - annualreviews.org
The central nervous system (CNS) is a sanctuary site and is protected by various barriers.
These regulate brain homeostasis and the transport of endogenous and exogenous …

Peptide mediated brain delivery of nano-and submicroparticles: a synergistic approach

M McCully, M Sanchez-Navarro… - Current …, 2018 - ingentaconnect.com
The brain is a complex, regulated organ with a highly controlled access mechanism: The
Blood-Brain Barrier (BBB). The selectivity of this barrier is a double-edged sword, being both …

The route of nanomaterials entering brain

Y Liu, Q He - Neurotoxicity of Nanomaterials and Nanomedicine, 2017 - Elsevier
The blood–brain barrier (BBB) provides a stable and safe environment for physiological
function of the central nervous system (CNS) as a protective barrier. However, the existence …

Drug delivery to the brain across the blood–brain barrier using nanomaterials

YH Tsou, XQ Zhang, H Zhu, S Syed, X Xu - Small, 2017 - Wiley Online Library
A major obstacle facing brain diseases such as Alzheimer's disease, multiple sclerosis,
brain tumors, and strokes is the blood–brain barrier (BBB). The BBB prevents the passage of …

[HTML][HTML] Peptide based drug delivery systems to the brain

Y Islam, AG Leach, J Smith, S Pluchino… - Nano …, 2020 - iopscience.iop.org
With estimated worldwide cost over $1 trillion just for dementia, diseases of the central
nervous system pose a major problem to health and healthcare systems, with significant …

[HTML][HTML] Blood-brain barrier and delivery of protein and gene therapeutics to brain

WM Pardridge - Frontiers in aging neuroscience, 2020 - frontiersin.org
Alzheimer's disease (AD) and treatment of the brain in aging require the development of
new biologic drugs, such as recombinant proteins or gene therapies. Biologics are large …

[HTML][HTML] Targeted drug delivery to the central nervous system using extracellular vesicles

L Zhou, S Kodidela, S Godse, S Thomas-Gooch… - Pharmaceuticals, 2022 - mdpi.com
The blood brain barrier (BBB) maintains the homeostasis of the central nervous system
(CNS) and protects the brain from toxic substances present in the circulating blood …

Delivery of peptide and protein drugs over the blood–brain barrier

I Brasnjevic, HWM Steinbusch, C Schmitz… - Progress in …, 2009 - Elsevier
Peptide and protein (P/P) drugs have been identified as showing great promises for the
treatment of various neurodegenerative diseases. A major challenge in this regard …

Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier

G Sharma, AR Sharma, SS Lee, M Bhattacharya… - International journal of …, 2019 - Elsevier
The blood brain barrier (BBB) offers protection to the central nervous system (CNS) by
maintaining homeostasis. Besides restricting the entry of harmful xenobiotics and …